Gastrointestinal adverse events such as diarrhea, nausea, vomiting, and decreased appetite were more common with tirzepatide than placebo or basal insulin but similar to GLP-1 receptor agonists [11]
Additionally, if you are planning pregnancy or become pregnant, contact your GP immediately, as Rybelsus is not recommended during pregnancy or breastfeeding
No crash
Independently tested by Freedom Diagnostics Testing HPLC/LC-MS purity & identity confirmation
GLP-1 users prioritize protein per bite and favor high fiber, while shunning sugar and seeking small serving sizes, healthy snacks, and new beverages
Tirzepatide works on multiple levels to support weight loss by: Suppressing appetite, enhancing fullness, and promoting fat burning create an environment where sustainable weight loss becomes achievable